_version_ 1783260690557960192
author He, Lingfeng
Luo, Libo
Zhu, Hong
Yang, Huan
Zhang, Yilan
Wu, Huan
Sun, Hongfang
Jiang, Feng
Kathera, Chandra S.
Liu, Lingjie
Zhuang, Ziheng
Chen, Haoyan
Pan, Feiyan
Hu, Zhigang
Zhang, Jing
Guo, Zhigang
author_facet He, Lingfeng
Luo, Libo
Zhu, Hong
Yang, Huan
Zhang, Yilan
Wu, Huan
Sun, Hongfang
Jiang, Feng
Kathera, Chandra S.
Liu, Lingjie
Zhuang, Ziheng
Chen, Haoyan
Pan, Feiyan
Hu, Zhigang
Zhang, Jing
Guo, Zhigang
author_sort He, Lingfeng
collection PubMed
description
format Online
Article
Text
id pubmed-5579339
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-55793392017-09-06 FEN1 promotes tumor progression and confers cisplatin resistance in non‐small‐cell lung cancer He, Lingfeng Luo, Libo Zhu, Hong Yang, Huan Zhang, Yilan Wu, Huan Sun, Hongfang Jiang, Feng Kathera, Chandra S. Liu, Lingjie Zhuang, Ziheng Chen, Haoyan Pan, Feiyan Hu, Zhigang Zhang, Jing Guo, Zhigang Mol Oncol Corrigendum John Wiley and Sons Inc. 2017-09-01 2017-09 /pmc/articles/PMC5579339/ /pubmed/28861953 http://dx.doi.org/10.1002/1878-0261.12118 Text en © 2017 The Authors. Published by FEBS Press and John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Corrigendum
He, Lingfeng
Luo, Libo
Zhu, Hong
Yang, Huan
Zhang, Yilan
Wu, Huan
Sun, Hongfang
Jiang, Feng
Kathera, Chandra S.
Liu, Lingjie
Zhuang, Ziheng
Chen, Haoyan
Pan, Feiyan
Hu, Zhigang
Zhang, Jing
Guo, Zhigang
FEN1 promotes tumor progression and confers cisplatin resistance in non‐small‐cell lung cancer
title FEN1 promotes tumor progression and confers cisplatin resistance in non‐small‐cell lung cancer
title_full FEN1 promotes tumor progression and confers cisplatin resistance in non‐small‐cell lung cancer
title_fullStr FEN1 promotes tumor progression and confers cisplatin resistance in non‐small‐cell lung cancer
title_full_unstemmed FEN1 promotes tumor progression and confers cisplatin resistance in non‐small‐cell lung cancer
title_short FEN1 promotes tumor progression and confers cisplatin resistance in non‐small‐cell lung cancer
title_sort fen1 promotes tumor progression and confers cisplatin resistance in non‐small‐cell lung cancer
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5579339/
https://www.ncbi.nlm.nih.gov/pubmed/28861953
http://dx.doi.org/10.1002/1878-0261.12118
work_keys_str_mv AT helingfeng fen1promotestumorprogressionandconferscisplatinresistanceinnonsmallcelllungcancer
AT luolibo fen1promotestumorprogressionandconferscisplatinresistanceinnonsmallcelllungcancer
AT zhuhong fen1promotestumorprogressionandconferscisplatinresistanceinnonsmallcelllungcancer
AT yanghuan fen1promotestumorprogressionandconferscisplatinresistanceinnonsmallcelllungcancer
AT zhangyilan fen1promotestumorprogressionandconferscisplatinresistanceinnonsmallcelllungcancer
AT wuhuan fen1promotestumorprogressionandconferscisplatinresistanceinnonsmallcelllungcancer
AT sunhongfang fen1promotestumorprogressionandconferscisplatinresistanceinnonsmallcelllungcancer
AT jiangfeng fen1promotestumorprogressionandconferscisplatinresistanceinnonsmallcelllungcancer
AT katherachandras fen1promotestumorprogressionandconferscisplatinresistanceinnonsmallcelllungcancer
AT liulingjie fen1promotestumorprogressionandconferscisplatinresistanceinnonsmallcelllungcancer
AT zhuangziheng fen1promotestumorprogressionandconferscisplatinresistanceinnonsmallcelllungcancer
AT chenhaoyan fen1promotestumorprogressionandconferscisplatinresistanceinnonsmallcelllungcancer
AT panfeiyan fen1promotestumorprogressionandconferscisplatinresistanceinnonsmallcelllungcancer
AT huzhigang fen1promotestumorprogressionandconferscisplatinresistanceinnonsmallcelllungcancer
AT zhangjing fen1promotestumorprogressionandconferscisplatinresistanceinnonsmallcelllungcancer
AT guozhigang fen1promotestumorprogressionandconferscisplatinresistanceinnonsmallcelllungcancer